Related Experiment Videos
Alcohol metabolism and fetal hypoplasia in chick brain
1Department of Biochemistry, East Carolina University School of Medicine, Greenville, NC 27858.
Insights
Early chick embryos show varied alcohol metabolism, with higher activity protecting against alcohol-induced brain growth inhibition. This suggests individual differences in fetal alcohol metabolism may explain varying effects in human pregnancies.
Area of Science:
- Developmental Biology
- Toxicology
- Pharmacology
Background:
- Ethanol exposure during early development can lead to significant growth deficits.
- Individual susceptibility to developmental toxicity varies, but underlying mechanisms are not fully understood.
- Alcohol dehydrogenase (ADH) is a key enzyme in ethanol metabolism.
Purpose of the Study:
- To investigate the role of embryonic alcohol metabolism in susceptibility to ethanol-induced growth inhibition.
- To explore the impact of inhibiting alcohol clearance on ethanol's teratogenic effects.
- To identify potential protective mechanisms against developmental alcohol toxicity.
Main Methods:
- Administering a single dose of ethanol (1.0 g/kg) to chick embryos on day 0 of incubation.
- Measuring blood alcohol levels and whole body/brain weight on day 7.
- Utilizing 4-methylpyrazole (an ADH inhibitor) and indomethacin (an anti-inflammatory drug) to modulate alcohol metabolism and effects.
Main Results:
- Significant inverse correlation observed between day 7 blood alcohol levels and both whole body and brain weight.
- 4-methylpyrazole treatment inhibited alcohol clearance and potentiated ethanol's brain growth inhibition.
- Indomethacin treatment reduced day 7 blood alcohol levels and protected against growth inhibition.
Conclusions:
- Chick embryos exhibit variable alcohol dehydrogenase-like metabolic activity, influencing ethanol's teratogenic impact.
- Higher endogenous alcohol metabolism appears protective against ethanol-induced brain growth inhibition in this model.
- Variations in fetal alcohol metabolism could explain differential outcomes in human pregnancies exposed to alcohol.
Abstract:
Chick embryos given a single dose of ethanol (1.0 g/kg) at the start of incubation (day 0) had widely differing levels of blood alcohol when sacrificed on day 7 and the blood alcohol levels were inversely correlated with whole body and brain weight. Clearance of the alcohol by the embryos was inhibited by simultaneous treatment with 4-methyl pyrazole and this treatment potentiated the brain growth inhibition due to ethanol. Treatment with indomethacin lowered blood alcohol levels on day 7 and protected against the growth inhibition. These data suggest that early chick embryos have varying amounts of alcohol dehydrogenase-like metabolic activity and that higher levels of this activity protect against alcohol-induced brain growth inhibition in this model. If similar variations in the ability to metabolize alcohol exist in human fetuses, it may represent a mechanism by which comparable maternal doses of alcohol produce widely varying fetal effects.